Compare Capital One Financial Corp. (COF) vs Cytokinetics Inc (CYTK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Capital One Financial Corp. vs Cytokinetics Inc — how do they compare? Capital One Financial Corp. trades at $219.37 (market cap $134.33B), while Cytokinetics Inc trades at $76.66 (market cap $10.78B). The key difference: Capital One Financial Corp. is far larger — about 12.5× Cytokinetics Inc's market cap, and Capital One Financial Corp. pays a 1.46% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| COF | CYTK | |
|---|---|---|
Market Cap | $134.33B | $10.78B |
Sector | Financials | Technology |
52-Week High | $257.94 | $87.26 |
52-Week Low | $176.10 | $34.31 |
Dividend Yield | 1.46% | — |
Enterprise Value | — | $10.88B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Cytokinetics (CYTK) trades at $76.76, down 5.67% today, with a bearish technical signal and negative profitability metrics. Recent Q2 2026 earnings beat EPS estimates but missed on revenue, while the company's drug Myqorzo shows strong commercial uptake and regulatory approvals in the UK. Cash flow remains negative from operations, offset by financing activities.
The outlook is mixed: strong analyst buy ratings (97%) and a $111.14 price target suggest upside, but high cash burn, competitive pressures, and lack of profitability pose significant risks. Investment appeal hinges on successful drug commercialization and path to profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Capital One Financial Corp.
Capital One is a diversified financial services holding company headquartered in McLean, Virginia. Originally a spinoff of Signet Financial's credit card division in 1994, the company is now primarily involved in credit card lending, auto loans, and commercial lending.
Read more on COF →About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →
